Successful treatment of glucocorticoid and cyclosporine refractory adult-onset still's disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab: A case report

Japanese Journal of Clinical Immunology

Volumn 36, Issue 6, 2013, Pages 478-483

  Yoji, Komiya ^a   Kenchi, Takenaka ^a   Kenji, Nagasaka ^a  

^a Ome Municipal General Hospital   (Japan)

Author keywords

Adult onset still's disease; Hemophagocytic syndrome; Plasma exchange; Tocilizumab

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYCLOSPORIN; FERRITIN; GLUCOCORTICOID; TOCILIZUMAB; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISOLONE;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FEVER; HEMOPHAGOCYTIC SYNDROME; HUMAN; LEUKOCYTOSIS; LYMPHADENOPATHY; PLASMAPHERESIS; RASH; SORE THROAT; DRUG COMBINATION; DRUG PULSE THERAPY; MULTIMODALITY CANCER THERAPY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; METHYLPREDNISOLONE; PLASMA EXCHANGE; PREDNISOLONE; PULSE THERAPY, DRUG; SEVERITY OF ILLNESS INDEX; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 84907249292     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.36.478     Document Type: Article

References (24)

1. Yamaguchi, M., et al.: Preliminary criteria for classification of adult Still's disease. J Rheu-matol. 19: 424-430, 1992
2. Arlet, JB., et al.: Reactive hemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis. 65: 1596-1601, 2006
3. Fautrel, B., et al.: Corticosteroid sparing eŠect of low dose methotrexate treatment in adult Still's disease. J Rheumatol. 26: 373 378, 1999.
4. Marchesoni, A., et al.: Cyclosporin A in the treatment of adult onset Still's disease. J Rheu-matol. 24: 1582-1587, 1997
5. Murakami, K., et al.: Successful treatment of a patient with refractory adult Still's disease by tacrolimus. Mod Rheumatol. 17: 167-170, 2007
6. Kraetsch, HG., et al.: Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis. 60 (Suppl 3): iii55-iii57, 2001
7. Puechal, X., et al.: Tocilizumab in refractory adult Still's disease. Arthritis Care Res. 63: 155-159, 2011
8. Kaneko, K., et al.: Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration. Int J Rheum Dis. 13: 67-69, 2010
9. Kato, T., et al.: Double-filtration plasmaphere-sis for resolution of corticosteroid resistant adult onset Still's disease. Clin Rheumatol. 25: 579-582, 2006.
10. Kuek, A., et al.: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford). 46: 1043-1044, 2007
11. Fautrel, B., et al.: Tumour necrosis factor al-pha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis. 64: 262-266, 2005
12. Boysson, H., et al.: Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence. Clin Rheumatol. 32: 141-147, 2013
13. Maeshima, K., et al.: Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept. Mod Rheumatol. 22: 137 141, 2012
14. Kobayashi, M., et al.: Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol. 21: 92-96, 2011.
15. Stern, A., et al.: Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy. J Clin Rheumatol. 7: 252-256, 2001
16. Fautrel, B.: Adult-onset Still disease. Best Pract Res Clin Rheumatol. 22: 773-792, 2008
17. Yoshizaki, A., et al.: Preferential recovery by an intensive initial therapy from hemophagocytic syndrome complicated with adult onset Still's disease presenting as agranulocytosis and hypercytokinemia. Clin Exp Rheumatol. 26: 383, 2008
18. Shimizu, M., et al.: Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. Cytokine. 58: 287 294, 2012
19. Nishida, T., et al.: Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness. Intern Med. 40: 1037 1040, 2001
20. Ito, T., et al.: Successful treatment with plasma exchange in adult-onset Still's disease with hyper-IL-18-naemia and hyperallergic state. Mod Rheumatol. 18: 407-410, 2008
21. Kettelhack, C., et al.: Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recom-483 binant human tumor necrosis factor-alpha and melphalan. Crit Care Med. 28: 1040-1046, 2000
22. Chen, DY., et al.: Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease. Ann Rheum Dis. 68: 1074-1075, 2009
23. Ames, PR., et al.: Multi-organ failure in adult onset Still's disease: a septic disguise. Clin Rheumatol. 28: S3-6, 2009
24. Scire, CA., et al.: Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol. 24: 123-128, 2006